Targeted Delivery of Bortezomib Using Retinoid-Based Nanoparticle: Modulating Liver Fibrosis through the TGF-β1/Smad3 Pathway
BTZ, in low amounts entrapped in targeted NPc, could ameliorate the fibrotic index in mice models.
Authors
- Mohammad Reza Zali (ORCID: https://orcid.org/0000-0002-9027-4560)
- Nosratollah Zarghami (ORCID: https://orcid.org/0000-0002-4236-4537)
- Kaveh Baghaei (ORCID: https://orcid.org/0000-0003-2102-9729)
- Abbas Ebrahimi‐Kalan (ORCID: https://orcid.org/0000-0001-5466-6754)
- Samaneh Siapoush (ORCID: https://orcid.org/0000-0001-7032-9459)
- Mohammad Rahmati‐Yamchi (ORCID: https://orcid.org/0000-0001-7791-3287)
- Behzad Hatami (ORCID: https://orcid.org/0000-0001-9635-4345)
- Morteza Milani (ORCID: https://orcid.org/0000-0002-9822-703X)
Institutions
- Tabriz University of Medical Sciences (IR)
- Istanbul Aydın University (TR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Advanced Pharmaceutical Bulletin
- Published
- 2025-02-12
- DOI
- https://doi.org/10.34172/apb.43295
- Citations
- 1
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- University of Tabriz